	Survival Probability (95% Confidence Interval)
	Total Population		White		Black		Other		Unknown
	Number	Percentage	Number	Percentage	Number	Percentage	Number	Percentage	Number	Percentage
	5-Year Survival
Sample Size	25,652	67.5%	21,143	67.4%	1791	63.8%	2455	69.6%	263	87.2%
Age at diagnosis
0 - 19 years	15,971	87.5%	12,973	87.7%	1122	83.6%	1496	87.7%	200	95.4%
20 - 39 years	3611	48.9%	2949	48.8%	232	40.0%	391	55.8%	39	47.4%
40 - 59 years	3271	34.6%	2700	34.4%	248	29.0%	308	39.4%	15	83.3%
>60 years	2979	16.5%	2521	16.3%	189	14.8%	260	18.8%	9	55.6%
Diagnosis era
2000-2009	12,047	65.4%	10,091	65.6%	840	61.1%	1059	66.7%	57	80.9%
2010-2019	13,605	69.6%	11,052	69.3%	951	66.2%	1396	72.0%	206	91.1%
Sex
Male	14,522	67.3%	12,053	67.0%	986	64.8%	1329	70.4%	154	85.5%
Female	11,130	67.8%	9090	67.9%	805	62.5%	1126	68.7%	109	89.5%
All phenotypes
T-cell	2221	65.5%	1,660	67.6%	305	57.2%	242	60.8%	14	77.9%
B-cell	18,068	68.1%	15,080	67.8%	1114	66.5%	1728	69.9%	146	89.0%
Unknown lineage	2534	62.7%	2157	62.6%	179	53.9%	177	72.1%	21	80.0%
Other	2829	69.9%	2246	68.6%	193	66.7%	308	83.3%	82	--
	10-Year Survival
Sample Size	25,652	64.0%	21,143	63.8%	1791	60.2%	2455	66.5%	263	86.1%
Age at diagnosis
0 - 19 years	15,971	84.7%	12,973	84.9%	1122	80.8%	1496	84.9%	200	95.4%
20 - 39 years	3611	44.3%	2949	44.0%	232	33.9%	391	52.7%	39	--
40 - 59 years	3271	28.7%	2700	28.4%	248	23.5%	308	34.8%	15	55.5%
>60 years	2979	10.6%	2521	10.3%	189	8.7%	260	14.4%	9	55.6%
Diagnosis era
2000-2009	12,047	62.0%	10,091	62.1%	840	57.7%	1059	63.3%	57	80.9%
2010-2019	--	--	--	--	--	--	--	--	--	--
Sex
Male	14,522	63.4%	12,053	63.1%	986	60.8%	1329	66.8%	154	83.7%
Female	11,130	64.7%	9090	64.7%	805	59.4%	1126	66.1%	109	89.5%
All phenotypes
T-cell	2221	63.3%	1660	65.5%	305	55.6%	242	57.1%	14	77.9%
B-cell	18,068	64.3%	15,080	63.9%	1114	62.3%	1728	67.1%	146	87.5%
Unknown lineage	2534	59.6%	2157	59.5%	179	51.1%	177	67.4%	21	80.0%
Other	2829	67.5%	2246	65.5%	193	66.7%	308	83.3%	82	--